DURLOBACTAM | DURLOBACTAM | ANTIINFECTIVES A DIAZABICYCLOOCTANE BETA LACTAMASE INHIBITOR TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA (HABP/VABP) CAUSED BY SUSCEPTIBLE ISOLATES OF ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX | INTRAVENOUS | Cmax 105.3 MICROMOLAR VD 30.3 LITER PPB 10 PERCENT Cl 9.96 LITER / HOUR HT 2.52 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | BETA LACTAMASE | beta-lactamase UNIPROT S5MN77 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |